Curemarkllc Is A Clinical Stage Biopharmaceutical Company Based In Rye Brooknew Yorkfounded In 2007 By Drjoan Fallonthe Company Is Dedicated To Developing Innovative Therapies For Neurological Disordersparticularly Focusing On Autism Spectrum Disorderasd Curemark Employs A Patient Centered Research Approachusing Clinical Observations To Guide Its Drug Development Efforts One Of Curemark S Key Products Is Cm Ata Proprietary Enzyme Replacement Therapy Designed To Address Pancreatic Enzyme Deficiencies In Children With Asdthis Therapy Aims To Improve Core Symptoms Such As Communication And Social Interactionwhich Currently Lack Fda Approved Treatmentsthe Company Also Engages In Research Collaborations To Advance Drug Discovery For Neurological Diseasespartnering With Institutions Like The Molecular Sciences Institute Curemark Is Committed To Addressing Unmet Medical Needs In Pediatric Patients With Asdhighlighting The Significant Economic Burden Of Treatment In The U Sthe Company Continues To Focus On Research Into Neurological And Metabolic Disorderssupported By Funding Initiatives To Enhance Its Clinical Trials And Development Pipeline
